After nearly a decade of treatment, a Texas woman reached remission through an FDA-approved cellular therapy for chronic lymphocytic leukemia.
The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results